Second Arm - Two Arm, Randomised (2:1), Open- label Phase 11/111 Study in EpCAM Positive Cancer Patients with Symptomatic Malignant Ascites Using Paracentesis Plus the Tri-Functional Antibody Removab (Anti-EpCAM x Anti-CD3 versus Paracent.

  • Poole, Christopher (Principal Investigator)

Project Details

Short titleSecond Arm - Two Arm, Randomised (2:1), Open- label Phase 11/111 Study in EpCAM Positive Cancer Patients with Symptomatic Malignant Ascites Using Paracentesis Plus the Tri-Functional Antibody Removab (Anti-EpCAM x Anti-CD3 versus Paracent.
StatusFinished
Effective start/end date1/10/0431/12/06

Funding

  • Queen Elizabeth Hospital Birmingham